

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.83660736 |
| 2 | viral transcription (GO:0019083) | 5.56732219 |
| 3 | translational termination (GO:0006415) | 5.40348964 |
| 4 | DNA deamination (GO:0045006) | 5.27459095 |
| 5 | maturation of SSU-rRNA (GO:0030490) | 5.22586047 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.96737410 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 4.88665265 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 4.83078979 |
| 9 | protein targeting to ER (GO:0045047) | 4.80292121 |
| 10 | translational elongation (GO:0006414) | 4.65834478 |
| 11 | ribosomal large subunit biogenesis (GO:0042273) | 4.53403769 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 4.50806090 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.49673434 |
| 14 | rRNA modification (GO:0000154) | 4.41654251 |
| 15 | pinocytosis (GO:0006907) | 4.28823274 |
| 16 | viral life cycle (GO:0019058) | 4.26017127 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.25246665 |
| 18 | GDP-mannose metabolic process (GO:0019673) | 4.24878543 |
| 19 | cellular protein complex disassembly (GO:0043624) | 4.24477128 |
| 20 | translational initiation (GO:0006413) | 4.22449352 |
| 21 | UV protection (GO:0009650) | 4.19730910 |
| 22 | protein maturation by protein folding (GO:0022417) | 4.15293487 |
| 23 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.09275799 |
| 24 | protein deneddylation (GO:0000338) | 4.06746202 |
| 25 | rRNA methylation (GO:0031167) | 4.05792200 |
| 26 | proteasome assembly (GO:0043248) | 4.02404127 |
| 27 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96165744 |
| 28 | translation (GO:0006412) | 3.90504890 |
| 29 | cullin deneddylation (GO:0010388) | 3.89896246 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.87587179 |
| 31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.86178994 |
| 32 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.85963801 |
| 33 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.81725830 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.79819288 |
| 35 | protein complex disassembly (GO:0043241) | 3.76150255 |
| 36 | DNA strand elongation (GO:0022616) | 3.73792946 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.69926051 |
| 38 | mature B cell differentiation involved in immune response (GO:0002313) | 3.69674167 |
| 39 | COPI coating of Golgi vesicle (GO:0048205) | 3.69385526 |
| 40 | Golgi transport vesicle coating (GO:0048200) | 3.69385526 |
| 41 | formation of translation preinitiation complex (GO:0001731) | 3.68579462 |
| 42 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.65850406 |
| 43 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.65850406 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.59914223 |
| 45 | macromolecular complex disassembly (GO:0032984) | 3.58634538 |
| 46 | termination of RNA polymerase III transcription (GO:0006386) | 3.58426406 |
| 47 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.58426406 |
| 48 | proline biosynthetic process (GO:0006561) | 3.57748077 |
| 49 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.57058687 |
| 50 | 7-methylguanosine mRNA capping (GO:0006370) | 3.56828550 |
| 51 | rRNA processing (GO:0006364) | 3.55288791 |
| 52 | barbed-end actin filament capping (GO:0051016) | 3.51135154 |
| 53 | spliceosomal complex assembly (GO:0000245) | 3.49451823 |
| 54 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.49302768 |
| 55 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.49302768 |
| 56 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.49208250 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.48153716 |
| 58 | negative regulation of ligase activity (GO:0051352) | 3.48153716 |
| 59 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.46966391 |
| 60 | 7-methylguanosine RNA capping (GO:0009452) | 3.46794875 |
| 61 | RNA capping (GO:0036260) | 3.46794875 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.46312923 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.46312923 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.46312923 |
| 65 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.46032819 |
| 66 | telomere maintenance via recombination (GO:0000722) | 3.44447741 |
| 67 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.43938700 |
| 68 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.41085868 |
| 69 | spliceosomal snRNP assembly (GO:0000387) | 3.41040785 |
| 70 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.40475912 |
| 71 | viral mRNA export from host cell nucleus (GO:0046784) | 3.40403247 |
| 72 | DNA replication checkpoint (GO:0000076) | 3.40155006 |
| 73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.39653314 |
| 74 | rRNA metabolic process (GO:0016072) | 3.37676352 |
| 75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.35260292 |
| 76 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.35260292 |
| 77 | cellular component biogenesis (GO:0044085) | 3.35017617 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31466975 |
| 79 | establishment of integrated proviral latency (GO:0075713) | 3.30317453 |
| 80 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.30143791 |
| 81 | purine nucleobase biosynthetic process (GO:0009113) | 3.29386212 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.29272988 |
| 83 | ribosome biogenesis (GO:0042254) | 3.29246849 |
| 84 | * deoxyribonucleotide catabolic process (GO:0009264) | 3.28370425 |
| 85 | nucleobase biosynthetic process (GO:0046112) | 3.28036216 |
| 86 | negative regulation of B cell apoptotic process (GO:0002903) | 3.26179356 |
| 87 | mRNA catabolic process (GO:0006402) | 3.25899084 |
| 88 | regulation of mitochondrial translation (GO:0070129) | 3.24271858 |
| 89 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.21250134 |
| 90 | pentose-phosphate shunt (GO:0006098) | 3.20372703 |
| 91 | pseudouridine synthesis (GO:0001522) | 3.19723565 |
| 92 | * deoxyribose phosphate catabolic process (GO:0046386) | 3.18830906 |
| 93 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.18624989 |
| 94 | CENP-A containing nucleosome assembly (GO:0034080) | 3.18030643 |
| 95 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.16758179 |
| 96 | telomere maintenance via telomere lengthening (GO:0010833) | 3.15279234 |
| 97 | DNA replication initiation (GO:0006270) | 3.14411724 |
| 98 | * purine deoxyribonucleotide catabolic process (GO:0009155) | 3.12841775 |
| 99 | RNA catabolic process (GO:0006401) | 3.09912151 |
| 100 | mitotic recombination (GO:0006312) | 3.09325894 |
| 101 | chromatin remodeling at centromere (GO:0031055) | 3.07837844 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.07105747 |
| 103 | NADH dehydrogenase complex assembly (GO:0010257) | 3.06827857 |
| 104 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.06827857 |
| 105 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.06827857 |
| 106 | protein complex biogenesis (GO:0070271) | 3.03248820 |
| 107 | protein targeting to membrane (GO:0006612) | 3.02696209 |
| 108 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.99892988 |
| 109 | negative regulation of cell size (GO:0045792) | 2.99474330 |
| 110 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.97933024 |
| 111 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97818383 |
| 112 | nucleotide salvage (GO:0043173) | 2.96716081 |
| 113 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.94829434 |
| 114 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.94088419 |
| 115 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.93556216 |
| 116 | metallo-sulfur cluster assembly (GO:0031163) | 2.91175184 |
| 117 | iron-sulfur cluster assembly (GO:0016226) | 2.91175184 |
| 118 | transcription from RNA polymerase I promoter (GO:0006360) | 2.89909464 |
| 119 | glucose catabolic process (GO:0006007) | 2.89474079 |
| 120 | DNA damage response, detection of DNA damage (GO:0042769) | 2.87219204 |
| 121 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.87129089 |
| 122 | positive regulation of cell cycle arrest (GO:0071158) | 2.86554635 |
| 123 | folic acid metabolic process (GO:0046655) | 2.86487106 |
| 124 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.85354316 |
| 125 | cell cycle G1/S phase transition (GO:0044843) | 2.85354316 |
| 126 | positive regulation of viral transcription (GO:0050434) | 2.84148009 |
| 127 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.83888002 |
| 128 | chaperone-mediated protein transport (GO:0072321) | 2.83419220 |
| 129 | type B pancreatic cell proliferation (GO:0044342) | 2.77709513 |
| 130 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.77171827 |
| 131 | hyaluronan catabolic process (GO:0030214) | 2.75540630 |
| 132 | viral protein processing (GO:0019082) | 2.75049414 |
| 133 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.74683000 |
| 134 | virion assembly (GO:0019068) | 2.73173969 |
| 135 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.69638942 |
| 136 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.69638942 |
| 137 | prostaglandin biosynthetic process (GO:0001516) | 2.69416105 |
| 138 | prostanoid biosynthetic process (GO:0046457) | 2.69416105 |
| 139 | NADPH regeneration (GO:0006740) | 2.69002613 |
| 140 | autophagic vacuole fusion (GO:0000046) | 2.68052138 |
| 141 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68007975 |
| 142 | pentose metabolic process (GO:0019321) | 2.67959574 |
| 143 | nuclear envelope reassembly (GO:0031468) | 2.66917314 |
| 144 | mitotic nuclear envelope reassembly (GO:0007084) | 2.66917314 |
| 145 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.66705783 |
| 146 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.63439374 |
| 147 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.62076778 |
| 148 | purine nucleotide salvage (GO:0032261) | 2.61746443 |
| 149 | purine ribonucleotide transport (GO:0015868) | 2.60949706 |
| 150 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.58002534 |
| 151 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.57413239 |
| 152 | * deoxyribose phosphate metabolic process (GO:0019692) | 2.55103872 |
| 153 | immunoglobulin mediated immune response (GO:0016064) | 2.55042731 |
| 154 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.54045602 |
| 155 | response to peptidoglycan (GO:0032494) | 2.52503367 |
| 156 | oxidative phosphorylation (GO:0006119) | 2.49620169 |
| 157 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.49531428 |
| 158 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.49107180 |
| 159 | adenine nucleotide transport (GO:0051503) | 2.46458682 |
| 160 | galactose catabolic process (GO:0019388) | 2.45340863 |
| 161 | pyrimidine-containing compound salvage (GO:0008655) | 2.42413657 |
| 162 | pyrimidine nucleoside salvage (GO:0043097) | 2.42413657 |
| 163 | GTP biosynthetic process (GO:0006183) | 2.41629736 |
| 164 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.40939915 |
| 165 | actin nucleation (GO:0045010) | 2.40470709 |
| 166 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.39782123 |
| 167 | extracellular fibril organization (GO:0043206) | 2.38567734 |
| 168 | regulation of B cell apoptotic process (GO:0002902) | 2.38235009 |
| 169 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37616927 |
| 170 | * purine deoxyribonucleotide metabolic process (GO:0009151) | 2.37338111 |
| 171 | proline metabolic process (GO:0006560) | 2.37132799 |
| 172 | response to interferon-beta (GO:0035456) | 2.35873886 |
| 173 | lipopolysaccharide metabolic process (GO:0008653) | 2.35761672 |
| 174 | heme biosynthetic process (GO:0006783) | 2.35631649 |
| 175 | UTP biosynthetic process (GO:0006228) | 2.31114511 |
| 176 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.26479618 |
| 177 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.26291589 |
| 178 | CTP biosynthetic process (GO:0006241) | 2.25196290 |
| 179 | CTP metabolic process (GO:0046036) | 2.25196290 |
| 180 | regulation of mast cell degranulation (GO:0043304) | 2.24984731 |
| 181 | regulation of mitochondrial membrane potential (GO:0051881) | 2.24778455 |
| 182 | fibril organization (GO:0097435) | 2.24240975 |
| 183 | positive regulation of B cell differentiation (GO:0045579) | 2.23326018 |
| 184 | UTP metabolic process (GO:0046051) | 2.22402377 |
| 185 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.21464743 |
| 186 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.18514931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.99345377 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.38210915 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.01948946 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.96891259 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.89524257 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.76431578 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.63807908 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.41789872 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.25293505 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.06122147 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03012395 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.00497029 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92213728 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.91999795 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.88972483 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.82639411 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.76297797 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.70527770 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64640841 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.64229608 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.59262002 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.56928366 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55488436 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.43020202 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.42522029 |
| 26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.40946273 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40598520 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.38413353 |
| 29 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37021646 |
| 30 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.33314967 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33291498 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.28272319 |
| 33 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.26163389 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.21728676 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16376595 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11251075 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.11126132 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09681341 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.06138321 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.01951247 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.01553945 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.00546741 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.98551789 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.96675730 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.94519089 |
| 46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.94398542 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.91019702 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85717829 |
| 49 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.85295811 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.84151363 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81477776 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81191486 |
| 53 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79798291 |
| 54 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.77139296 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75579370 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73312036 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72003171 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71179177 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65392188 |
| 60 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65240096 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64812485 |
| 62 | * P68_20966046_ChIP-Seq_HELA_Human | 1.61903645 |
| 63 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.61645416 |
| 64 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60611375 |
| 65 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59528539 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.59036666 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57958551 |
| 68 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56942593 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56412948 |
| 70 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53034492 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49434878 |
| 72 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.48886908 |
| 73 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48861700 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46084774 |
| 75 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44671347 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.41125877 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.38392302 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37793736 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37558894 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.37516188 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37117426 |
| 82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36894730 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36632530 |
| 84 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.34921824 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33742625 |
| 86 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33124823 |
| 87 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32793554 |
| 88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.31921903 |
| 89 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.31412074 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31223826 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30290810 |
| 92 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28938104 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28820806 |
| 94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.28439583 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28387367 |
| 96 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26801770 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26316636 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23774572 |
| 99 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23638365 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23514729 |
| 101 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.23347066 |
| 102 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20221805 |
| 103 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20190176 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20021162 |
| 105 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.19500258 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19028676 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18436000 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17815672 |
| 109 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14767194 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14288928 |
| 111 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14228922 |
| 112 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13123556 |
| 113 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13057600 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12046210 |
| 115 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11302788 |
| 116 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11065589 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11036291 |
| 118 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10088569 |
| 119 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09933880 |
| 120 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09146047 |
| 121 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09143963 |
| 122 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08686718 |
| 123 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08561287 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08440747 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08385600 |
| 126 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07538406 |
| 127 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07442062 |
| 128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07407884 |
| 129 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.06502051 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05941439 |
| 131 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04469882 |
| 132 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.04240488 |
| 133 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.03691493 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02515666 |
| 135 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99846256 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97903903 |
| 137 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95173401 |
| 138 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94726835 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94420006 |
| 140 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92726014 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92523046 |
| 142 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91804558 |
| 143 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91217972 |
| 144 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89923669 |
| 145 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89486471 |
| 146 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89405914 |
| 147 | * MYC_22102868_ChIP-Seq_BL_Human | 0.88104345 |
| 148 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88007037 |
| 149 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87700264 |
| 150 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85261421 |
| 151 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84947876 |
| 152 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83724327 |
| 153 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82916705 |
| 154 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.80291276 |
| 155 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77885790 |
| 156 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.75748956 |
| 157 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.74239058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.01583935 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.81146025 |
| 3 | MP0004147_increased_porphyrin_level | 3.70413780 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.46706634 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.32611575 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.21392134 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.02918610 |
| 8 | MP0008057_abnormal_DNA_replication | 2.93536831 |
| 9 | MP0009840_abnormal_foam_cell | 2.93000942 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.80342749 |
| 11 | MP0003077_abnormal_cell_cycle | 2.78747888 |
| 12 | MP0009278_abnormal_bone_marrow | 2.73816955 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.71245613 |
| 14 | MP0005451_abnormal_body_composition | 2.69176737 |
| 15 | MP0009697_abnormal_copulation | 2.65729229 |
| 16 | MP0008058_abnormal_DNA_repair | 2.59515518 |
| 17 | MP0003279_aneurysm | 2.40164729 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.33681930 |
| 19 | MP0002132_abnormal_respiratory_system | 2.31530865 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.30150548 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.13242418 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.10719528 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 2.07352532 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 2.03397832 |
| 25 | MP0003123_paternal_imprinting | 1.99954136 |
| 26 | MP0010030_abnormal_orbit_morphology | 1.98698327 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.96237887 |
| 28 | MP0002102_abnormal_ear_morphology | 1.92417565 |
| 29 | MP0008932_abnormal_embryonic_tissue | 1.86329684 |
| 30 | MP0003786_premature_aging | 1.85529660 |
| 31 | MP0002163_abnormal_gland_morphology | 1.80488166 |
| 32 | MP0005671_abnormal_response_to | 1.78834780 |
| 33 | MP0001542_abnormal_bone_strength | 1.77448949 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.76946942 |
| 35 | MP0000490_abnormal_crypts_of | 1.76033669 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.71643939 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.70278776 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.70027178 |
| 39 | MP0003121_genomic_imprinting | 1.69885698 |
| 40 | MP0000750_abnormal_muscle_regeneration | 1.69181562 |
| 41 | MP0003122_maternal_imprinting | 1.68559001 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.61031018 |
| 43 | MP0008260_abnormal_autophagy | 1.59851057 |
| 44 | MP0004858_abnormal_nervous_system | 1.58282367 |
| 45 | MP0005025_abnormal_response_to | 1.57496319 |
| 46 | MP0002398_abnormal_bone_marrow | 1.56078554 |
| 47 | MP0000681_abnormal_thyroid_gland | 1.54617658 |
| 48 | MP0002419_abnormal_innate_immunity | 1.53248399 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.51750210 |
| 50 | MP0001958_emphysema | 1.49849949 |
| 51 | MP0001188_hyperpigmentation | 1.48726394 |
| 52 | MP0005408_hypopigmentation | 1.48620602 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.45713491 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.44680828 |
| 55 | MP0001293_anophthalmia | 1.44625963 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.43171571 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.37394520 |
| 58 | MP0000751_myopathy | 1.37057935 |
| 59 | MP0003186_abnormal_redox_activity | 1.36598560 |
| 60 | MP0002938_white_spotting | 1.35942317 |
| 61 | MP0004272_abnormal_basement_membrane | 1.35668786 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.33872506 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.33375888 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.32861176 |
| 65 | MP0003303_peritoneal_inflammation | 1.32656873 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.30496826 |
| 67 | MP0000343_altered_response_to | 1.29583835 |
| 68 | MP0003075_altered_response_to | 1.29347488 |
| 69 | MP0001529_abnormal_vocalization | 1.28862455 |
| 70 | MP0005390_skeleton_phenotype | 1.28810983 |
| 71 | MP0001873_stomach_inflammation | 1.28256243 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.26700586 |
| 73 | MP0002722_abnormal_immune_system | 1.26394348 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.26020646 |
| 75 | MP0000350_abnormal_cell_proliferation | 1.24840776 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.21875864 |
| 77 | MP0005165_increased_susceptibility_to | 1.21652932 |
| 78 | MP0001661_extended_life_span | 1.21389662 |
| 79 | MP0002160_abnormal_reproductive_system | 1.20325093 |
| 80 | * MP0002019_abnormal_tumor_incidence | 1.20089779 |
| 81 | * MP0002429_abnormal_blood_cell | 1.19719282 |
| 82 | MP0009785_altered_susceptibility_to | 1.18581956 |
| 83 | * MP0000313_abnormal_cell_death | 1.17150929 |
| 84 | MP0000858_altered_metastatic_potential | 1.16110973 |
| 85 | MP0005330_cardiomyopathy | 1.14782050 |
| 86 | MP0006054_spinal_hemorrhage | 1.13713414 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 1.12913825 |
| 88 | MP0003718_maternal_effect | 1.12726087 |
| 89 | MP0000015_abnormal_ear_pigmentation | 1.12718673 |
| 90 | MP0005501_abnormal_skin_physiology | 1.11259117 |
| 91 | MP0005360_urolithiasis | 1.10878637 |
| 92 | MP0003566_abnormal_cell_adhesion | 1.10755803 |
| 93 | MP0002095_abnormal_skin_pigmentation | 1.10223849 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 1.09255814 |
| 95 | MP0001730_embryonic_growth_arrest | 1.08669383 |
| 96 | * MP0000716_abnormal_immune_system | 1.07943634 |
| 97 | MP0001800_abnormal_humoral_immune | 1.07824291 |
| 98 | MP0005508_abnormal_skeleton_morphology | 1.05692331 |
| 99 | MP0005275_abnormal_skin_tensile | 1.05576951 |
| 100 | MP0002060_abnormal_skin_morphology | 1.03520248 |
| 101 | MP0002998_abnormal_bone_remodeling | 1.02591076 |
| 102 | MP0002933_joint_inflammation | 1.02417784 |
| 103 | MP0005503_abnormal_tendon_morphology | 1.00379386 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.99531900 |
| 105 | MP0008469_abnormal_protein_level | 0.98992651 |
| 106 | MP0000678_abnormal_parathyroid_gland | 0.97615486 |
| 107 | MP0002420_abnormal_adaptive_immunity | 0.97362606 |
| 108 | MP0001819_abnormal_immune_cell | 0.97143115 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.96530681 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.96530681 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.95636003 |
| 112 | MP0002210_abnormal_sex_determination | 0.94841413 |
| 113 | MP0002080_prenatal_lethality | 0.94744920 |
| 114 | MP0005670_abnormal_white_adipose | 0.94021749 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.93834039 |
| 116 | MP0002452_abnormal_antigen_presenting | 0.93498522 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.92882476 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.91457128 |
| 119 | MP0001881_abnormal_mammary_gland | 0.91400371 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.90977040 |
| 121 | MP0001186_pigmentation_phenotype | 0.90669110 |
| 122 | MP0001145_abnormal_male_reproductive | 0.89160312 |
| 123 | MP0003119_abnormal_digestive_system | 0.88370774 |
| 124 | MP0010155_abnormal_intestine_physiology | 0.87211720 |
| 125 | MP0001790_abnormal_immune_system | 0.86492175 |
| 126 | MP0005387_immune_system_phenotype | 0.86492175 |
| 127 | MP0005023_abnormal_wound_healing | 0.85649289 |
| 128 | MP0000358_abnormal_cell_content/ | 0.85637080 |
| 129 | MP0009764_decreased_sensitivity_to | 0.85243786 |
| 130 | MP0003787_abnormal_imprinting | 0.84960502 |
| 131 | MP0005389_reproductive_system_phenotype | 0.84939020 |
| 132 | MP0001853_heart_inflammation | 0.84557517 |
| 133 | MP0003795_abnormal_bone_structure | 0.84459576 |
| 134 | MP0009053_abnormal_anal_canal | 0.84436953 |
| 135 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83515253 |
| 136 | MP0004947_skin_inflammation | 0.83203050 |
| 137 | MP0000685_abnormal_immune_system | 0.83098247 |
| 138 | MP0000747_muscle_weakness | 0.82704742 |
| 139 | MP0004510_myositis | 0.82092916 |
| 140 | MP0005220_abnormal_exocrine_pancreas | 0.81914029 |
| 141 | MP0002723_abnormal_immune_serum | 0.81055330 |
| 142 | MP0006082_CNS_inflammation | 0.80609532 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80493621 |
| 144 | MP0002405_respiratory_system_inflammati | 0.79925834 |
| 145 | MP0001697_abnormal_embryo_size | 0.79909558 |
| 146 | MP0002282_abnormal_trachea_morphology | 0.79381370 |
| 147 | MP0005380_embryogenesis_phenotype | 0.78639274 |
| 148 | MP0001672_abnormal_embryogenesis/_devel | 0.78639274 |
| 149 | MP0003315_abnormal_perineum_morphology | 0.78213837 |
| 150 | MP0000477_abnormal_intestine_morphology | 0.77352622 |
| 151 | MP0003448_altered_tumor_morphology | 0.77129501 |
| 152 | MP0003436_decreased_susceptibility_to | 0.76674066 |
| 153 | MP0000767_abnormal_smooth_muscle | 0.75276674 |
| 154 | MP0002751_abnormal_autonomic_nervous | 0.74579999 |
| 155 | * MP0005000_abnormal_immune_tolerance | 0.74461238 |
| 156 | MP0002148_abnormal_hypersensitivity_rea | 0.74339066 |
| 157 | MP0008789_abnormal_olfactory_epithelium | 0.73443501 |
| 158 | MP0001243_abnormal_dermal_layer | 0.72779607 |
| 159 | MP0001929_abnormal_gametogenesis | 0.72178202 |
| 160 | MP0000049_abnormal_middle_ear | 0.71834784 |
| 161 | MP0000653_abnormal_sex_gland | 0.71035656 |
| 162 | MP0001919_abnormal_reproductive_system | 0.70594552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.84673878 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.46360081 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 5.04829030 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.00064390 |
| 5 | Reticulocytopenia (HP:0001896) | 4.65656044 |
| 6 | Macrocytic anemia (HP:0001972) | 4.20929907 |
| 7 | Increased hepatocellular lipid droplets (HP:0006565) | 3.96968967 |
| 8 | Pallor (HP:0000980) | 3.88878925 |
| 9 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.74563012 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.73716376 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.71820572 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 3.67316560 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.55406436 |
| 14 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.53419574 |
| 15 | Aplastic anemia (HP:0001915) | 3.47797970 |
| 16 | Respiratory difficulties (HP:0002880) | 3.44746208 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42161208 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42161208 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42161208 |
| 20 | Oral leukoplakia (HP:0002745) | 3.35915009 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.20124100 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.20124100 |
| 23 | Exertional dyspnea (HP:0002875) | 3.10929737 |
| 24 | Mitochondrial inheritance (HP:0001427) | 3.08177559 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 3.06090969 |
| 26 | 11 pairs of ribs (HP:0000878) | 3.05038030 |
| 27 | Breast hypoplasia (HP:0003187) | 2.98311903 |
| 28 | Dysostosis multiplex (HP:0000943) | 2.93214367 |
| 29 | Increased CSF lactate (HP:0002490) | 2.89555483 |
| 30 | Petechiae (HP:0000967) | 2.85845802 |
| 31 | IgM deficiency (HP:0002850) | 2.80118839 |
| 32 | Hypertensive crisis (HP:0100735) | 2.75542345 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73801113 |
| 34 | Increased serum lactate (HP:0002151) | 2.72460300 |
| 35 | 3-Methylglutaconic aciduria (HP:0003535) | 2.67535831 |
| 36 | Joint stiffness (HP:0001387) | 2.63993705 |
| 37 | Achilles tendon contracture (HP:0001771) | 2.62862739 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60269869 |
| 39 | Obstructive lung disease (HP:0006536) | 2.60269869 |
| 40 | Type I transferrin isoform profile (HP:0003642) | 2.59713999 |
| 41 | J-shaped sella turcica (HP:0002680) | 2.56169277 |
| 42 | Hepatocellular necrosis (HP:0001404) | 2.50612511 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.50141604 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.46718708 |
| 45 | Abnormal lung lobation (HP:0002101) | 2.45912546 |
| 46 | Abnormal gallbladder physiology (HP:0012438) | 2.43407300 |
| 47 | Cholecystitis (HP:0001082) | 2.43407300 |
| 48 | Patellar aplasia (HP:0006443) | 2.43035389 |
| 49 | Abnormal number of incisors (HP:0011064) | 2.41757923 |
| 50 | Premature graying of hair (HP:0002216) | 2.41743300 |
| 51 | Microvesicular hepatic steatosis (HP:0001414) | 2.40687752 |
| 52 | Acute encephalopathy (HP:0006846) | 2.39785921 |
| 53 | Abnormality of the umbilical cord (HP:0010881) | 2.39780547 |
| 54 | Generalized amyotrophy (HP:0003700) | 2.39039734 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.37073494 |
| 56 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.36187689 |
| 57 | Entropion (HP:0000621) | 2.33030021 |
| 58 | Cervical subluxation (HP:0003308) | 2.32917462 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.31574531 |
| 60 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30972094 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28604086 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28604086 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28604086 |
| 64 | Rough bone trabeculation (HP:0100670) | 2.27628656 |
| 65 | Pancytopenia (HP:0001876) | 2.26558398 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.26429997 |
| 67 | Cellulitis (HP:0100658) | 2.25624153 |
| 68 | IgG deficiency (HP:0004315) | 2.24797810 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 2.23375454 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.23375454 |
| 71 | Elbow flexion contracture (HP:0002987) | 2.22839774 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.22311586 |
| 73 | Trismus (HP:0000211) | 2.20431841 |
| 74 | Hepatic necrosis (HP:0002605) | 2.17747004 |
| 75 | Absent thumb (HP:0009777) | 2.17590731 |
| 76 | Progressive macrocephaly (HP:0004481) | 2.15337354 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14259635 |
| 78 | Abnormality of renal resorption (HP:0011038) | 2.13867304 |
| 79 | Lactic acidosis (HP:0003128) | 2.13189656 |
| 80 | Bulbar palsy (HP:0001283) | 2.12524292 |
| 81 | Facial cleft (HP:0002006) | 2.11042492 |
| 82 | Stridor (HP:0010307) | 2.10532780 |
| 83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.10283315 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 2.10099715 |
| 85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09354352 |
| 86 | Exercise intolerance (HP:0003546) | 2.09299754 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.09213693 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09213693 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.08172351 |
| 90 | Rhabdomyolysis (HP:0003201) | 2.06720409 |
| 91 | Myopathic facies (HP:0002058) | 2.06698795 |
| 92 | Biconcave vertebral bodies (HP:0004586) | 2.06250079 |
| 93 | Pulmonary fibrosis (HP:0002206) | 2.05755214 |
| 94 | Redundant skin (HP:0001582) | 2.04785699 |
| 95 | Reduced antithrombin III activity (HP:0001976) | 2.04384919 |
| 96 | Abnormality of reticulocytes (HP:0004312) | 2.04257162 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 2.04022477 |
| 98 | Asplenia (HP:0001746) | 2.02381224 |
| 99 | Type 1 muscle fiber predominance (HP:0003803) | 2.01626467 |
| 100 | Hyperphosphaturia (HP:0003109) | 2.00735451 |
| 101 | Ankle contracture (HP:0006466) | 2.00365216 |
| 102 | Purpura (HP:0000979) | 1.97889021 |
| 103 | Testicular atrophy (HP:0000029) | 1.97246682 |
| 104 | Hand muscle atrophy (HP:0009130) | 1.97151956 |
| 105 | Progressive muscle weakness (HP:0003323) | 1.96403564 |
| 106 | Slender long bone (HP:0003100) | 1.96221934 |
| 107 | Degeneration of anterior horn cells (HP:0002398) | 1.95645729 |
| 108 | Abnormality of the anterior horn cell (HP:0006802) | 1.95645729 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94234940 |
| 110 | Triphalangeal thumb (HP:0001199) | 1.93738565 |
| 111 | Blue sclerae (HP:0000592) | 1.93419423 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 1.92503652 |
| 113 | Depressed nasal ridge (HP:0000457) | 1.90988082 |
| 114 | Thrombocytosis (HP:0001894) | 1.90574445 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 1.89907751 |
| 116 | Increased muscle lipid content (HP:0009058) | 1.89291300 |
| 117 | Vertebral compression fractures (HP:0002953) | 1.88871736 |
| 118 | Spinal rigidity (HP:0003306) | 1.88250686 |
| 119 | Cerebral palsy (HP:0100021) | 1.86767091 |
| 120 | Increased connective tissue (HP:0009025) | 1.85196510 |
| 121 | Premature skin wrinkling (HP:0100678) | 1.85055755 |
| 122 | Multiple enchondromatosis (HP:0005701) | 1.84895216 |
| 123 | Abnormal protein glycosylation (HP:0012346) | 1.84398048 |
| 124 | Abnormal glycosylation (HP:0012345) | 1.84398048 |
| 125 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84398048 |
| 126 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84398048 |
| 127 | Optic nerve coloboma (HP:0000588) | 1.84337901 |
| 128 | Esophageal neoplasm (HP:0100751) | 1.83350641 |
| 129 | Neoplasm of head and neck (HP:0012288) | 1.83350641 |
| 130 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.82812606 |
| 131 | Horseshoe kidney (HP:0000085) | 1.82748041 |
| 132 | Bladder diverticulum (HP:0000015) | 1.82318675 |
| 133 | Supernumerary spleens (HP:0009799) | 1.81700138 |
| 134 | Fragile skin (HP:0001030) | 1.81651780 |
| 135 | Selective tooth agenesis (HP:0001592) | 1.80813111 |
| 136 | Abnormal trabecular bone morphology (HP:0100671) | 1.79750699 |
| 137 | Poor head control (HP:0002421) | 1.79199475 |
| 138 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78997118 |
| 139 | Bone marrow hypocellularity (HP:0005528) | 1.78838534 |
| 140 | Congenital, generalized hypertrichosis (HP:0004540) | 1.78666337 |
| 141 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.77623794 |
| 142 | Single umbilical artery (HP:0001195) | 1.77623794 |
| 143 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.77623794 |
| 144 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.77013147 |
| 145 | Spondylolisthesis (HP:0003302) | 1.76942674 |
| 146 | Thin bony cortex (HP:0002753) | 1.76818500 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.76632822 |
| 148 | Carpal bone hypoplasia (HP:0001498) | 1.75252737 |
| 149 | Hyperacusis (HP:0010780) | 1.75041960 |
| 150 | Nonimmune hydrops fetalis (HP:0001790) | 1.73863735 |
| 151 | Abnormality of the tricuspid valve (HP:0001702) | 1.73860125 |
| 152 | Secondary amenorrhea (HP:0000869) | 1.73184516 |
| 153 | Lymphoma (HP:0002665) | 1.72522748 |
| 154 | Hypochromic anemia (HP:0001931) | 1.71913071 |
| 155 | Sparse eyelashes (HP:0000653) | 1.71828259 |
| 156 | Easy fatigability (HP:0003388) | 1.71636194 |
| 157 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71045706 |
| 158 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70461929 |
| 159 | Dicarboxylic aciduria (HP:0003215) | 1.70461929 |
| 160 | Pancreatic fibrosis (HP:0100732) | 1.70256869 |
| 161 | Muscle stiffness (HP:0003552) | 1.69050494 |
| 162 | Recurrent sinusitis (HP:0011108) | 1.68936094 |
| 163 | Microretrognathia (HP:0000308) | 1.68403445 |
| 164 | Hypertriglyceridemia (HP:0002155) | 1.68144852 |
| 165 | Fatigue (HP:0012378) | 1.66967944 |
| 166 | Wormian bones (HP:0002645) | 1.66755321 |
| 167 | Opisthotonus (HP:0002179) | 1.66084336 |
| 168 | Tongue fasciculations (HP:0001308) | 1.65882554 |
| 169 | Neutropenia (HP:0001875) | 1.65574775 |
| 170 | Cerebral edema (HP:0002181) | 1.64960189 |
| 171 | Abnormal spermatogenesis (HP:0008669) | 1.64945096 |
| 172 | Cellular immunodeficiency (HP:0005374) | 1.64923906 |
| 173 | Pancreatic cysts (HP:0001737) | 1.62728483 |
| 174 | Glycosuria (HP:0003076) | 1.62419275 |
| 175 | Abnormality of urine glucose concentration (HP:0011016) | 1.62419275 |
| 176 | Meckel diverticulum (HP:0002245) | 1.62200519 |
| 177 | Abnormal hair whorl (HP:0010721) | 1.62065880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.95787051 |
| 2 | BRD4 | 3.92469223 |
| 3 | TLK1 | 3.34293381 |
| 4 | ERN1 | 3.18007118 |
| 5 | NME2 | 3.13049680 |
| 6 | EIF2AK1 | 2.90391492 |
| 7 | PIM2 | 2.70202172 |
| 8 | TRIB3 | 2.63879947 |
| 9 | STK16 | 2.61818076 |
| 10 | SCYL2 | 2.57679041 |
| 11 | VRK2 | 2.48791747 |
| 12 | WEE1 | 2.45215158 |
| 13 | ACVR1B | 2.34860406 |
| 14 | CDC7 | 2.27021053 |
| 15 | PLK4 | 2.25386450 |
| 16 | SRPK1 | 2.20245617 |
| 17 | VRK1 | 2.10973946 |
| 18 | MUSK | 2.04151994 |
| 19 | ARAF | 1.96966581 |
| 20 | TBK1 | 1.93622778 |
| 21 | LIMK1 | 1.92091972 |
| 22 | NME1 | 1.87785792 |
| 23 | MKNK2 | 1.77386086 |
| 24 | MKNK1 | 1.75709631 |
| 25 | MAP3K12 | 1.70723467 |
| 26 | IRAK4 | 1.69041204 |
| 27 | ABL2 | 1.56674333 |
| 28 | MAPKAPK3 | 1.55754755 |
| 29 | PRPF4B | 1.52118706 |
| 30 | TIE1 | 1.50783570 |
| 31 | PLK1 | 1.49476786 |
| 32 | BRSK2 | 1.45216419 |
| 33 | BRSK1 | 1.40762244 |
| 34 | BRAF | 1.27642674 |
| 35 | SMG1 | 1.26755924 |
| 36 | MAP3K11 | 1.26600728 |
| 37 | SIK1 | 1.22023932 |
| 38 | PLK3 | 1.20748132 |
| 39 | CCNB1 | 1.20405405 |
| 40 | TEC | 1.20149192 |
| 41 | BCKDK | 1.18664308 |
| 42 | CDK8 | 1.18448546 |
| 43 | TGFBR1 | 1.18219419 |
| 44 | CDK7 | 1.16401951 |
| 45 | ILK | 1.15756288 |
| 46 | MAP3K14 | 1.14260137 |
| 47 | DYRK3 | 1.09926386 |
| 48 | RPS6KB2 | 1.08012835 |
| 49 | DYRK2 | 1.06159746 |
| 50 | MAP2K2 | 1.03424116 |
| 51 | MAP4K1 | 1.02933404 |
| 52 | EIF2AK3 | 1.02528734 |
| 53 | ATR | 1.02166460 |
| 54 | AURKB | 1.00380383 |
| 55 | NEK2 | 0.99640160 |
| 56 | PAK4 | 0.99202315 |
| 57 | AURKA | 0.96092832 |
| 58 | PKN2 | 0.95016289 |
| 59 | TTN | 0.94782024 |
| 60 | DAPK1 | 0.94267673 |
| 61 | TYK2 | 0.94125474 |
| 62 | PASK | 0.93429531 |
| 63 | PRKD2 | 0.92922970 |
| 64 | CDK19 | 0.92594455 |
| 65 | EIF2AK2 | 0.91687376 |
| 66 | FLT3 | 0.90904278 |
| 67 | DAPK3 | 0.90503987 |
| 68 | EEF2K | 0.90369335 |
| 69 | JAK3 | 0.90063193 |
| 70 | CASK | 0.89726896 |
| 71 | EPHA2 | 0.88515438 |
| 72 | PIM1 | 0.86766695 |
| 73 | ZAK | 0.84546235 |
| 74 | TTK | 0.83148178 |
| 75 | PRKCI | 0.83013745 |
| 76 | ZAP70 | 0.82370607 |
| 77 | IKBKB | 0.81669175 |
| 78 | TESK2 | 0.81496624 |
| 79 | TAOK2 | 0.79359138 |
| 80 | TSSK6 | 0.78048975 |
| 81 | KDR | 0.77771554 |
| 82 | TESK1 | 0.75750035 |
| 83 | SYK | 0.75687969 |
| 84 | MAP3K13 | 0.75059423 |
| 85 | IKBKE | 0.72561361 |
| 86 | FES | 0.72559309 |
| 87 | BTK | 0.71840329 |
| 88 | CSNK2A1 | 0.71791270 |
| 89 | LRRK2 | 0.71399107 |
| 90 | PLK2 | 0.69198081 |
| 91 | BMPR2 | 0.68572409 |
| 92 | BMPR1B | 0.68175148 |
| 93 | RPS6KA2 | 0.67307642 |
| 94 | MAP2K3 | 0.64527407 |
| 95 | LMTK2 | 0.64431387 |
| 96 | GRK6 | 0.64125021 |
| 97 | KIT | 0.62441724 |
| 98 | MOS | 0.60755482 |
| 99 | RPS6KA4 | 0.60133227 |
| 100 | NEK9 | 0.60004042 |
| 101 | RPS6KL1 | 0.59698612 |
| 102 | RPS6KC1 | 0.59698612 |
| 103 | MAPK11 | 0.58782287 |
| 104 | IRAK3 | 0.57395777 |
| 105 | FRK | 0.57126921 |
| 106 | PAK1 | 0.55601630 |
| 107 | TGFBR2 | 0.54929943 |
| 108 | CLK1 | 0.54831804 |
| 109 | CSNK2A2 | 0.54638382 |
| 110 | DDR2 | 0.54102454 |
| 111 | MAP3K3 | 0.53804999 |
| 112 | PDPK1 | 0.53680339 |
| 113 | CDK12 | 0.52564901 |
| 114 | RAF1 | 0.52475629 |
| 115 | CHEK2 | 0.52222887 |
| 116 | MAP4K2 | 0.51395307 |
| 117 | RPS6KA5 | 0.51037002 |
| 118 | BLK | 0.48340706 |
| 119 | MAP3K8 | 0.48121626 |
| 120 | NLK | 0.47464942 |
| 121 | ERBB3 | 0.46951809 |
| 122 | CHEK1 | 0.46382624 |
| 123 | CSF1R | 0.46164923 |
| 124 | LYN | 0.45722821 |
| 125 | PAK2 | 0.45561990 |
| 126 | SIK3 | 0.45423231 |
| 127 | CDK4 | 0.45213313 |
| 128 | PTK2 | 0.44524948 |
| 129 | STK10 | 0.43908024 |
| 130 | MAPKAPK2 | 0.43803847 |
| 131 | STK38L | 0.43331028 |
| 132 | TXK | 0.42600440 |
| 133 | RPS6KA6 | 0.42505955 |
| 134 | MAPK12 | 0.42253546 |
| 135 | TNK2 | 0.42241817 |
| 136 | MAP2K6 | 0.42153439 |
| 137 | YES1 | 0.41898836 |
| 138 | PRKD1 | 0.41840764 |
| 139 | MST4 | 0.39434479 |
| 140 | PIK3CG | 0.38358758 |
| 141 | CAMK2G | 0.38316113 |
| 142 | MAPK4 | 0.37486530 |
| 143 | MYLK | 0.37226284 |
| 144 | PRKG2 | 0.36306847 |
| 145 | MATK | 0.35643573 |
| 146 | MAP3K1 | 0.35404020 |
| 147 | ATM | 0.35008130 |
| 148 | AKT2 | 0.34145632 |
| 149 | RIPK4 | 0.33623718 |
| 150 | DYRK1B | 0.33608199 |
| 151 | PRKCD | 0.33495017 |
| 152 | MAP3K6 | 0.33397699 |
| 153 | EPHB2 | 0.31498086 |
| 154 | CSNK1G3 | 0.30452733 |
| 155 | PBK | 0.29486061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.13658373 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.50838554 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.96088939 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.76827875 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.49290843 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.28416398 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.82556517 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.80547899 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.79650643 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.58784553 |
| 11 | * Base excision repair_Homo sapiens_hsa03410 | 2.55628466 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.46677296 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.38613440 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.32035791 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.29308089 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 2.21878832 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 2.06336515 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.01935167 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00752215 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.95603150 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.87950362 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.84045449 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.73567266 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72910839 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.68963189 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.67858056 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.62139164 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52773354 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52650310 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50137775 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.48164446 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45509346 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.43916429 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40849501 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38767508 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.34827209 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33838353 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31735265 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.31272859 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27495068 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26767755 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14329451 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14111469 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10781822 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05898046 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05823130 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05291826 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01167341 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.00982517 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00413412 |
| 51 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.97167920 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93464101 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91934883 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90192128 |
| 55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89157311 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.86606314 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85206026 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83738334 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.81442650 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.78082512 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77260250 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72100671 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71369295 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69846377 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68024821 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66594803 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64911501 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.64830345 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64543192 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.63907663 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62838769 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.61184738 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60760041 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59757075 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59457015 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58398044 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57927818 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57499688 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57042286 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55884811 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.55475198 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.53476619 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.52906266 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52025125 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51199205 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.51198152 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50830589 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50143622 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49341116 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49134083 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48028701 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47694014 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46791519 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46494915 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46430960 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45589935 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.44927837 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44275821 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42957684 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41549141 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40880097 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40745450 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40051699 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38353965 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37993695 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34327568 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33283567 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33281439 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.29403898 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28734044 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.28114874 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27490072 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27403721 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.27393934 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26893934 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26415877 |
| 117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26333066 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25760616 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.25193853 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24275069 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.23479620 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22902815 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22852801 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.21569613 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21452932 |
| 126 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.21312926 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17638078 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.17404520 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.16895298 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.15251555 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14978353 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.11648252 |
| 133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.11530162 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.09614243 |
| 135 | Carbon metabolism_Homo sapiens_hsa01200 | 0.09603136 |
| 136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.09428133 |

